1093 related articles for article (PubMed ID: 17351403)
1. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
Arbel Y; Swartzon M; Justo D
Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced torsades de pointes in patients aged 80 years or more.
Paran Y; Mashav N; Henis O; Swartzon M; Arbel Y; Justo D
Anadolu Kardiyol Derg; 2008 Aug; 8(4):260-5. PubMed ID: 18676301
[TBL] [Abstract][Full Text] [Related]
3. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
[TBL] [Abstract][Full Text] [Related]
4. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
Oberg KC; Bauman JL
Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
[TBL] [Abstract][Full Text] [Related]
5. Torsade de pointes associated with hypokalemia after anthracycline treatment in a patient with acute lymphocytic leukemia.
Kishi S; Yoshida A; Yamauchi T; Tsutani H; Lee JD; Nakamura T; Naiki H; Ueda T
Int J Hematol; 2000 Feb; 71(2):172-9. PubMed ID: 10745628
[TBL] [Abstract][Full Text] [Related]
6. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
[TBL] [Abstract][Full Text] [Related]
7. Effect of arsenic trioxide on QT interval in patients with advanced malignancies.
Barbey JT; Pezzullo JC; Soignet SL
J Clin Oncol; 2003 Oct; 21(19):3609-15. PubMed ID: 14512391
[TBL] [Abstract][Full Text] [Related]
8. Torsades de pointes associated with voriconazole use.
Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
[TBL] [Abstract][Full Text] [Related]
9. Methadone-induced long QT syndrome vs methadone-induced torsades de pointes.
Justo D
Arch Intern Med; 2006 Nov; 166(20):2288; author reply 2289-90. PubMed ID: 17101953
[No Abstract] [Full Text] [Related]
10. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
Isbister GK; Balit CR; Macleod D; Duffull SB
J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced long QT syndrome and torsade de pointes.
Morissette P; Hreiche R; Turgeon J
Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
[TBL] [Abstract][Full Text] [Related]
13. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases.
Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T
J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140
[TBL] [Abstract][Full Text] [Related]
14. Frequency of high-risk use of QT-prolonging medications.
Allen LaPointe NM; Curtis LH; Chan KA; Kramer JM; Lafata JE; Gurwitz JH; Raebel MA; Platt R
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):361-8. PubMed ID: 16178046
[TBL] [Abstract][Full Text] [Related]
15. Torsades de pointes with methadone.
Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343
[TBL] [Abstract][Full Text] [Related]
16. ['Cardiac ballet' with and without amiodarone].
Balestra B; Hess T
Schweiz Med Wochenschr; 1993 Jan; 123(1-2):20-5. PubMed ID: 8421775
[TBL] [Abstract][Full Text] [Related]
17. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
Mok NS; Lo YK; Tsui PT; Lam CW
J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
[TBL] [Abstract][Full Text] [Related]
18. Methadone-associated Torsades de Pointes (polymorphic ventricular tachycardia) in opioid-dependent patients.
Justo D; Gal-Oz A; Paran Y; Goldin Y; Zeltser D
Addiction; 2006 Sep; 101(9):1333-8. PubMed ID: 16911733
[TBL] [Abstract][Full Text] [Related]
19. Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning.
Chang JH; Weng TI; Fang CC
Am J Emerg Med; 2009 Oct; 27(8):1016.e1-3. PubMed ID: 19857426
[TBL] [Abstract][Full Text] [Related]
20. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
Pearson EC; Woosley RL
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]